Pharmaceutical companies use "detailing" — brief meetings with clinicians — to change prescriber behavior. Learn how such techniques can help providers adopt safer opioid prescribing practices.
Pharmaceutical companies have proven that detailing — using brief, in-person visits to share "details" about a drug's efficacy — is an effective sales tool. "Academic detailing" borrows these techniques to support health care goals, including promoting cost-effective care through generic prescribing.
In this webinar, learn how the San Francisco Department of Public Health (SFDPH) cut opioid-related emergency visits in half by implementing detailing techniques — informing clinicians of the benefits of co-prescribing naloxone to patients on daily opioids. The team also developed academic detailing toolkits and training materials to support safer opioid prescribing practices.
This webinar reviews the data supporting academic detailing and describes practical approaches that can be used in your community.
- Emily Behar, MS, research study coordinator in the Substance Use Research Unit at the San Francisco Department of Public Health
A recording of the event, the presentation slides, and a guide published by the SFDPH are available below.